Coverage

New York Times columnist Thomas Friedman once wrote; “Everything really important happens the morning after the morning after…” In short, focus on what really changes, not what is said will change. That is a good lesson for the White House and…
Today, the U.S. Food and Drug Administration announced that it has begun a national search for a new Deputy Commissioner for Human Foods and is providing an update on last month’s proposed restructuring of the agency’s Human Foods…
Even as FDA kicks off a search for a deputy commissioner for its proposed Human Foods Program who it says will have a “clear line of authority over” all human food safety and nutrition programs, industry stakeholders worry agency is choosing a “business…
On Friday, the US Food and Drug Administration’s Center for Tobacco Products announced steps it would take to do a better job regulating tobacco products.
This week marks my one-year anniversary as the 25th Commissioner for Food and Drugs. I have been proud to represent the U.S. Food and Drug Administration and its talented and hard-working staff in these extraordinary times.  Read more
For years, pharmaceutical industry officials have argued that splitting the FDA into two agencies — one that regulates medical products, and one that regulates food — would improve efficiency. Read more
The Food and Drug Administration will create a senior position to oversee food safety and nutrition after a series of foodborne-illness crises, including a nationwide baby formula shortage, exposed major flaws in the agency’s…
  The head of the US Food and Drug Administration proposed sweeping changes to the agency’s food safety programs Tuesday in order to protect the US food supply and promote better nutrition. Read more
In July, I commissioned an external evaluation of the U.S. Food and Drug Administration’s Human Foods Program, including the Office of Food Policy and Response (OFPR), the Center for Food Safety and Applied Nutrition (CFSAN), as well as relevant parts…
Earlier this year, I commissioned an external evaluation of the U.S. Food and Drug Administration’s Tobacco Program, to be conducted by an external expert panel facilitated by the Reagan-Udall Foundation, led by former FDA Chief of Staff…